🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
The purpose of this study is to evaluate consistency in terms of the immune...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-11-09
Trial ID
NCT01702428
Treatments Being Tested
The goal of this observational study is to learn about vaccine immunity in ...
Status
Recruiting
Location
University Hospital Bern
Start Date
2023-11-14
Trial ID
NCT06333275
This study aims to provide evidence that co-administration of measles-mumps...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2016-10-13
Trial ID
NCT02880865
Treatments Being Tested
The purpose of this observer blinded study is to provide information on vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-20
Trial ID
NCT00578175
Treatments Being Tested
The purpose of this study is to support licensure of GSK Biologicals' MMR v...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06-21
Trial ID
NCT01621802
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
The purpose of the study is to evaluate the immunogenicity and safety of Ki...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-31
Trial ID
NCT00871117
Treatments Being Tested